Clinical Trial Update: Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ketamine as an adjunct to bupivacaine for paravertebral analgesia in breast cancer surgery; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Ketamine (ketamine)

Snippet

Sponsor: Assiut University | Conditions: Acute Pain, Chronic Pain | Phase 1, Phase 2 | Status: COMPLETED